Business Description

Bionomics Ltd
SIC : 2836
ISIN : AU000000BNO5
Compare
Compare
Traded in other countries / regions
BNOX.USAB1N0.GermanyBNO.Australia IPO Date
1999-12-21Description
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 34.18 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.78 | |||||
Beneish M-Score | -6.53 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -97.2 | |||||
3-Year FCF Growth Rate | -31.7 | |||||
3-Year Book Growth Rate | 8.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.33 | |||||
9-Day RSI | 41.17 | |||||
14-Day RSI | 40.99 | |||||
6-1 Month Momentum % | -55.17 | |||||
12-1 Month Momentum % | -74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.87 | |||||
Quick Ratio | 4.87 | |||||
Cash Ratio | 4.42 | |||||
Days Sales Outstanding | 514.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.9 | |||||
Shareholder Yield % | 0.59 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -145340.91 | |||||
Net Margin % | -144759.09 | |||||
FCF Margin % | -95918.18 | |||||
ROE % | -69.34 | |||||
ROA % | -58.04 | |||||
ROIC % | -125.03 | |||||
ROC (Joel Greenblatt) % | -5444.7 | |||||
ROCE % | -62.62 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.43 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | 0.48 | |||||
EV-to-Forward-EBIT | -0.09 | |||||
EV-to-EBITDA | 0.5 | |||||
EV-to-Forward-EBITDA | -0.06 | |||||
EV-to-Revenue | -699.82 | |||||
EV-to-Forward-Revenue | 0.51 | |||||
EV-to-FCF | 0.73 | |||||
Price-to-Net-Current-Asset-Value | 1 | |||||
Price-to-Net-Cash | 1 | |||||
Earnings Yield (Greenblatt) % | 208.33 | |||||
FCF Yield % | -143.68 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionomics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.022 | ||
EPS (TTM) (A$) | -0.012 | ||
Beta | 0 | ||
Volatility % | 55.46 | ||
14-Day RSI | 40.99 | ||
14-Day ATR (A$) | 0.001543 | ||
20-Day SMA (A$) | 0.010975 | ||
12-1 Month Momentum % | -74 | ||
52-Week Range (A$) | 0.009 - 0.074 | ||
Shares Outstanding (Mil) | 1,468.74 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bionomics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bionomics Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Bionomics Ltd Frequently Asked Questions
What is Bionomics Ltd(ASX:BNO)'s stock price today?
The current price of ASX:BNO is A$0.01. The 52 week high of ASX:BNO is A$0.07 and 52 week low is A$0.01.
When is next earnings date of Bionomics Ltd(ASX:BNO)?
The next earnings date of Bionomics Ltd(ASX:BNO) is 2024-01-19 Est..
Does Bionomics Ltd(ASX:BNO) pay dividends? If so, how much?
Bionomics Ltd(ASX:BNO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |